ethyl 7-methyl-3-(3-(4-sulfamoylphenethyl)ureido)pyrazolo[1,5-a]pyrimidine-6-carboxylate

ID: ALA4867657

PubChem CID: 164618855

Max Phase: Preclinical

Molecular Formula: C19H22N6O5S

Molecular Weight: 446.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1cnc2c(NC(=O)NCCc3ccc(S(N)(=O)=O)cc3)cnn2c1C

Standard InChI:  InChI=1S/C19H22N6O5S/c1-3-30-18(26)15-10-22-17-16(11-23-25(17)12(15)2)24-19(27)21-9-8-13-4-6-14(7-5-13)31(20,28)29/h4-7,10-11H,3,8-9H2,1-2H3,(H2,20,28,29)(H2,21,24,27)

Standard InChI Key:  MMZBHZUVIYNBBK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
   22.5347   -8.0811    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.9474   -8.7910    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   23.3558   -8.0786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6517   -9.6825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6517  -10.4997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3569  -10.9041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3569   -9.2698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0622   -9.6825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0667  -10.4961    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8419  -10.7434    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3166  -10.0824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8347   -9.4269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3574  -11.7213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9437  -10.9108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2354  -10.5032    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9449  -11.7279    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5283  -10.9128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8200  -10.5052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0829   -8.6483    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8813   -8.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1296   -7.6954    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4315   -9.0783    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2298   -8.9040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7800   -9.5082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5723   -9.3291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1196   -9.9286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9112   -9.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1529   -8.9736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5969   -8.3757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8073   -8.5574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5052   -9.3918    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  7  2  0
  5  6  2  0
  6  9  1  0
  8  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  2  0
  6 13  1  0
 14 15  1  0
 14 16  2  0
  5 14  1  0
 15 17  1  0
 17 18  1  0
 12 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 25 24  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 28  2  1  0
  2 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4867657

    ---

Associated Targets(Human)

CA5A Tclin Carbonic anhydrase VA (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.49Molecular Weight (Monoisotopic): 446.1372AlogP: 1.23#Rotatable Bonds: 7
Polar Surface Area: 157.78Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.16CX Basic pKa: 0.59CX LogP: 0.96CX LogD: 0.96
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.46Np Likeness Score: -1.91

References

1. Gumus A, Bozdag M, Angeli A, Peat TS, Carta F, Supuran CT, Selleri S..  (2021)  Privileged scaffolds in medicinal chemistry: Studies on pyrazolo[1,5-a]pyrimidines on sulfonamide containing Carbonic Anhydrase inhibitors.,  49  [PMID:34371130] [10.1016/j.bmcl.2021.128309]

Source